search
Back to results

Comparison of CPAP Modalities for OSA Treatment

Primary Purpose

Obstructive Sleep Apnea

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
CPAP Fixed Pressure
Sponsored by
Associação Fundo de Incentivo à Pesquisa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obstructive Sleep Apnea focused on measuring Sleep Apnea, CPAP

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • male gender
  • apnea-hypopnea index (AHI) score of ≥20 events/hour of sleep
  • 30-65 years-old
  • body mass index (BMI) ≤40 Kg/m²

Exclusion Criteria:

  • major neurological, psychiatric, cardiac or respiratory disease
  • use of psychoactive medication
  • other sleep disorders
  • patients referred to PSG for Bilevel, considered the need for PAP ≥ 18 cm H2O
  • Previous contact with any OSA treatment.

Sites / Locations

  • Evelyn BrasilRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

CPAP C- Flex-Plus by Philips Respironics

CPAP with Sensawake by Fisher and Paykel

CPAP fixed pressure

Arm Description

Four consecutive weeks with CPAP C- FLEX PLUS treatment. After these 4 weeks, patients will undergo full PSG with CPAP FLEX- PLUS. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.

Four consecutive weeks with CPAP Sensawake treatment. After these 4 weeks, patients will undergo full PSG with the same CPAP modality. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.

Four consecutive weeks with CPAP fixed pressure treatment. After these 4 weeks, patients will undergo full PSG with the same CPAP modality. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.

Outcomes

Primary Outcome Measures

Flow limitation
Flow limitation in percentage of total sleep time. The flow limitation will be assessed by the flow curve obtained in the polysomnographic recording.

Secondary Outcome Measures

Adherence to CPAP treatment
Adherence to CPAP treatment will be evaluated by CPAP SD card download data
Arousal index
Number of arousals per hour of sleep assessed by polysomnographic recording
Wake time after sleep onset
Wake time after sleep onset assessed by polysomnographic recording

Full Information

First Posted
May 5, 2017
Last Updated
December 16, 2017
Sponsor
Associação Fundo de Incentivo à Pesquisa
Collaborators
Fisher and Paykel Healthcare, Philips Respironics
search

1. Study Identification

Unique Protocol Identification Number
NCT03212209
Brief Title
Comparison of CPAP Modalities for OSA Treatment
Official Title
A Crossover Study Comparing Fixed Continuous Airway Positive Pressure, FLEX- PLUS and Sensawake Modalities for OSA Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Unknown status
Study Start Date
April 28, 2017 (Actual)
Primary Completion Date
February 14, 2018 (Anticipated)
Study Completion Date
July 16, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Associação Fundo de Incentivo à Pesquisa
Collaborators
Fisher and Paykel Healthcare, Philips Respironics

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a crossover study comparing the effect of CPAP Fixed Pressure, CPAP FLEX -PLUS and Sensawake on sleep quality, adherence to treatments, and PSG parameters in patients with moderate to severe OSA.
Detailed Description
Obstructive sleep apnea (OSA) is associated with behavioral, cognitive, metabolic and cardiovascular conditions. Continuous Positive Airway Pressure (CPAP) is the gold standard treatment for OSA. Despite being the most effective treatment for OSA, 46 to 83% of patients do not adhere to CPAP. New technologies for CPAP treatment have been developed in order to improve patient's comfort, adherence and effectiveness in reducing apnea, hypopneas and flow limitation events. As an example, the FLEX- PLUS technology which increases inspiratory positive pressure and decreases expiratory positive pressure would soften the rhythm of breathing. Sensawake is another technology which evaluates breathing pattern changes during CPAP therapy. When the breathing pattern suggests that patient is awake, a prompt relief in pressure is activated, like ramp feature. However, it is not clear whether CPAP FLEX- PLUS or Sensawake are superior compared with fixed pressure CPAP, in terms of polysomnographic parameters, especially flow limitation or adherence to treatment. Objective: To compare the effect of fixed pressure CPAP, CPAP FLEX- PLUS and Sensawake on sleep and compliance parameters in patients with moderate to severe OSA. Methods: Fifty male patients with moderate to severe OSA will be included in a crossover design study. All patients will use each CPAP modality for 30 days in a randomized order, namely CPAP with Fixed Pressure, Flex- PLUS and Sensawake. A week of washout period will be applied between treatments. All patients will wear the same nasal mask brand. At the end of each treatment (every 4 weeks), patients will undergo polysomnography and fill out Epworth, FOSQ, Pittsburgh questionnaires and a visual analogue scale assessing CPAP side effects and patient´s comfort. Finally, adherence to CPAP modalities will be systematically checked.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea
Keywords
Sleep Apnea, CPAP

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
This is a crossover study comparing different CPAP modalities in a group of patients with moderate to severe OSA.
Masking
ParticipantInvestigator
Masking Description
Participants have never had contact with CPAP, therefore were not aware of PAP modality prescribed. Investigator were also naive, as well as sleep specialist responsible for Polysomnography reports. Only respiratory therapist who was assigned to CPAP clinic was aware of patient´s treatment condition.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CPAP C- Flex-Plus by Philips Respironics
Arm Type
Experimental
Arm Description
Four consecutive weeks with CPAP C- FLEX PLUS treatment. After these 4 weeks, patients will undergo full PSG with CPAP FLEX- PLUS. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.
Arm Title
CPAP with Sensawake by Fisher and Paykel
Arm Type
Experimental
Arm Description
Four consecutive weeks with CPAP Sensawake treatment. After these 4 weeks, patients will undergo full PSG with the same CPAP modality. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.
Arm Title
CPAP fixed pressure
Arm Type
Active Comparator
Arm Description
Four consecutive weeks with CPAP fixed pressure treatment. After these 4 weeks, patients will undergo full PSG with the same CPAP modality. Patients will also fill out Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Functional Outcome Sleep Questionnaire, and visual analogue scale assessing CPAP side effects and patient´s comfort. Adherence to 4-week treatment will be checked. Treatment is followed by 7-day washout period.
Intervention Type
Device
Intervention Name(s)
CPAP Fixed Pressure
Other Intervention Name(s)
CPAP C- Flex Plus by Philips Respironics, CPAP with SensAwake by Fisher and Paykel
Intervention Description
Continuous positive airway pressure (CPAP) is the gold standard treatment for moderate and severe OSA, and it has been known to apply positive pressure in the upper airways, acting as a pneumatic splint preventing the upper airway collapse during sleep. CPAP C- Flex Plus by Philips - Respironics works just as CPAP Fixed Pressure, but increases the pressure delivered in the begining of inhalation to softens the breathing rhythm of the CPAP user. CPAP with SensAwake by Fisher and Paykel works just as CPAP fixed pressure but when the breathing pattern suggests that patient is awake, a prompt relief in pressure to the lowest most comfortable level is activated, like ramp feature.
Primary Outcome Measure Information:
Title
Flow limitation
Description
Flow limitation in percentage of total sleep time. The flow limitation will be assessed by the flow curve obtained in the polysomnographic recording.
Time Frame
4 weeks after each CPAP modality completion
Secondary Outcome Measure Information:
Title
Adherence to CPAP treatment
Description
Adherence to CPAP treatment will be evaluated by CPAP SD card download data
Time Frame
4 weeks after each CPAP modality completion
Title
Arousal index
Description
Number of arousals per hour of sleep assessed by polysomnographic recording
Time Frame
4 weeks after each CPAP modality completion
Title
Wake time after sleep onset
Description
Wake time after sleep onset assessed by polysomnographic recording
Time Frame
4 weeks after each CPAP modality completion

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: male gender apnea-hypopnea index (AHI) score of ≥20 events/hour of sleep 30-65 years-old body mass index (BMI) ≤40 Kg/m² Exclusion Criteria: major neurological, psychiatric, cardiac or respiratory disease use of psychoactive medication other sleep disorders patients referred to PSG for Bilevel, considered the need for PAP ≥ 18 cm H2O Previous contact with any OSA treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dalva Poyares, MD, PhD
Organizational Affiliation
AFIP - Associação de fundo e incentivo a pesquisa
Official's Role
Study Director
Facility Information:
Facility Name
Evelyn Brasil
City
São Paulo
ZIP/Postal Code
04024-002
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Evelyn Brasil, Pt
Phone
+5511996357766
Email
evelynlucien@yahoo.com.br
First Name & Middle Initial & Last Name & Degree
Dalva Poyares, MD,PhD
Phone
+5511985937418
Email
poyares@unifesp.br

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
In case there is a future metanalysis in the subject, required by an indexed Journal or author.

Learn more about this trial

Comparison of CPAP Modalities for OSA Treatment

We'll reach out to this number within 24 hrs